Myelosuppression after frontline fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: analysis of persistent and new-onset cytopenia

Cancer. 2014 Feb 1;120(3):451-2. doi: 10.1002/cncr.28443. Epub 2013 Oct 22.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Female
  • Humans
  • Immune Tolerance / drug effects*
  • Immunotherapy / adverse effects*
  • Leukemia, Lymphocytic, Chronic, B-Cell / therapy*
  • Male
  • Pancytopenia / chemically induced*